Literature DB >> 20652273

Assessment of heart rate recovery index in patients with familial Mediterranean fever.

Idris Ardic1, Mehmet Gungor Kaya, Mikail Yarlioglues, Orhan Dogdu, Mehmet Celikbilek, Mahmut Akpek, Lutfi Akyol, Edip Torun.   

Abstract

Heart rate recovery after exercise is a function of vagal reactivation, and its impairment is an independent prognostic indicator for cardiovascular and all-cause mortality. The aim of our study was to evaluate heart rate recovery in patients with familial Mediterranean fever (FMF). The study population included 38 patients with FMF (14 men; mean age, 36.2 ± 12.1 years, and mean disease duration = 11.3 ± 6.5 years) and 35 healthy control subjects (12 men; mean age = 34.1 ± 9.9 years). Basal electrocardiography, echocardiography, and treadmill exercise testing were performed in all patients and control participants. The heart rate recovery index was defined as the reduction in the heart rate from the rate at peak exercise to the rate 1st-minute (HRR(1)), 2nd-minute (HRR(2)), 3rd-minute (HRR(3)), and 5th-minute (HRR(5)) after the cessation of exercise stress testing. There are significant differences in HRR(1) and HRR(2) indices between patients with FMF and control group (26.4 ± 7.4 vs. 35.0 ± 8.0; P = 0.001 and 47.3 ± 11.8 vs. 54.8 ± 10.3; P = 0.002, respectively). Similarly, HRR(3) and HRR(5) indices of the recovery period were lower in patients with FMF, when compared with indices in the control group (56.0 ± 14.0 vs. 63.7 ± 11.2; P = 0.01 and 64.1 ± 14.7 vs. 71.5 ± 12.7; P = 0.02, respectively). There were also remarkably positive correlations between the disease duration and HRR(1) (r = 0.31, P = 0.02), and HRR(2) (r = 0.26, P = 0.04). The heart rate recovery index impaired in patients with FMF compared to control subjects. When the prognostic significance of the heart rate recovery index is considered, a useful, simple, and noninvasive test may be clinically helpful in the recognition of high-risk patients with FMF.

Entities:  

Mesh:

Year:  2010        PMID: 20652273     DOI: 10.1007/s00296-010-1550-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Impaired coronary microvascular function in familial Mediterranean fever.

Authors:  Mustafa Caliskan; Hakan Gullu; Sema Yilmaz; Dogan Erdogan; Gulhan Kanat Unler; Ozgur Ciftci; Semra Topcu; Zeynep Kayhan; Eftal Yucel; Haldun Muderrisoglu
Journal:  Atherosclerosis       Date:  2007-08-01       Impact factor: 5.162

2.  The relationship between resting heart rate variability and heart rate recovery.

Authors:  Michael R Esco; Michele S Olson; Henry N Williford; Daniel L Blessing; David Shannon; Peter Grandjean
Journal:  Clin Auton Res       Date:  2009-10-10       Impact factor: 4.435

3.  Heart-rate profile during exercise as a predictor of sudden death.

Authors:  Xavier Jouven; Jean-Philippe Empana; Peter J Schwartz; Michel Desnos; Dominique Courbon; Pierre Ducimetière
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

Review 4.  Autonomic dysfunction in rheumatic diseases.

Authors:  Rainer H Straub; Christoph G Baerwald; Matthias Wahle; Wilfrid Jänig
Journal:  Rheum Dis Clin North Am       Date:  2005-02       Impact factor: 2.670

5.  Prevalence of ischemic heart disease in patients with familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; L Neumann; D Buskila; J Shemer; D Amolsky; M Pras
Journal:  Isr Med Assoc J       Date:  2001-01       Impact factor: 0.892

6.  Cardiovascular autonomic dysfunction in familial Mediterranean fever.

Authors:  Michael Rozenbaum; Jochanan E Naschitz; Marina Yudashkin; Itzhak Rosner; Edmond Sabo; Naomi Shaviv; Luis Gaitini; Eli Zuckerman; Daniel Yeshurun
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

7.  Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF.

Authors:  Ali Akdogan; Meral Calguneri; Bunyamin Yavuz; E Bengi Arslan; Umut Kalyoncu; Levent Sahiner; Omer Karadag; Ihsan Ertenli; Sedat Kiraz; Kudret Aytemir; Deniz Akata; Lale Tokgozoglu; Ali Oto
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

8.  Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.

Authors:  Sahru Yüksel; Lilit Ayvazyan; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

9.  Autonomic contribution to heart rate recovery from exercise in humans.

Authors:  W M Savin; D M Davidson; W L Haskell
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-12

10.  Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure.

Authors:  K Imai; H Sato; M Hori; H Kusuoka; H Ozaki; H Yokoyama; H Takeda; M Inoue; T Kamada
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

View more
  4 in total

1.  Cardiac autonomic functions in children with familial Mediterranean fever.

Authors:  Murat Şahin; Mustafa Kır; Balahan Makay; Pembe Keskinoğlu; Elçin Bora; Erbil Ünsal; Nurettin Ünal
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

2.  Heart rate recovery is impaired in patients with psoriasis.

Authors:  Bahadir Sarli; Yasemin Dogan; Ahmet Oguz Baktir; Hayrettin Saglam; Huseyin Arinc; Serkan Kurtul; Atıl Avci; Levent Cinar; Mahmut Akpek; Mehmet G Kaya
Journal:  Med Princ Pract       Date:  2013-07-26       Impact factor: 1.927

3.  Impaired heart rate recovery indices in psoriasis patients.

Authors:  Esra Pancar Yuksel; Serkan Yuksel; Mustafa Yenercag; Korhan Soylu; Fatma Aydin; Nilgun Senturk; Huriye Yucel; Tayyar Canturk; Ahmet Yasar Turanli
Journal:  Med Sci Monit       Date:  2014-03-02

4.  Deteriorated Systolic Blood Pressure Recovery and Heart Rate Recovery After Graded Exercise in Children With Familial Mediterranean Fever.

Authors:  Havva Evrengül; Selçuk Yüksel; Mustafa Doğan; Dolunay Gürses; Harun Evrengül
Journal:  Arch Rheumatol       Date:  2017-04-05       Impact factor: 1.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.